Sudden Unexpected Death in Epilepsy

Lou Ferrari, Vice President of Medical Affairs at SK Life Science discusses Sudden Unexpected Death in Epilepsy (SUDEP), what essential information patients and families need to know, what questions to ask the physician, and what can be done to reduce risk.

With more than 30 years of experience in the pharmaceutical and biotech industries, Louis Ferrari has garnered a diverse set of experiences that have allowed him to navigate through complex regulatory environments and develop operational strategies on behalf of global companies. His wide-ranging expertise includes focuses in sales, marketing, clinical and finance and his work has impacted patients in various disease state categories. Louis’ ability to drive results and aptitude for operational excellence has allowed him to attain several leadership positions, including his role as President and CEO of Savient Pharmaceutical, a publicly traded company.

These unique and valuable experiences led Louis to his current role as Executive Director of Clinical Affairs at SK life science. Through his current position, he oversees the company’s Clinical Affairs team and is responsible for the dissemination of medical information, the development of standard operating procedures for various groups and defining KOLs. Throughout his tenure in the industry, Louis’ personal philosophy has always been to value the quality of life of patients above all else.